Godavari Biorefineries Share News - Latest Updates, Live News & More

Latest news about Godavari Biorefineries

Godavari Biorefineries Reports Q1 FY26 Turnaround with Positive EBITDA and Strategic Expansion Plans 10 days ago

Godavari Biorefineries Limited (GBL) reported improved Q1 FY26 results with revenue at INR 533.20 crores, up from INR 522.50 crores in Q1 FY25. The company achieved a positive EBITDA of INR 6.50 crores, reversing previous losses. Bio-based chemical segment EBITDA increased by 43%. GBL is expanding its ethanol production with a new 200 KLD grain-based distillery. The company projects 3x EBITDA growth from FY25 to FY29, driven by bio-based specialty chemicals and ethanol capacity expansion. GBL also made progress in drug discovery, receiving European and Chinese patents for anti-cancer compounds.

Godavari Biorefineries Secures Prestigious ICC K.V. Mariwala Award for 2024 Aug 15, 2025

Godavari Biorefineries Reports Turnaround in Q1 with Improved EBITDA Aug 11, 2025

Godavari Biorefineries Reports Mixed Q1 Results with Revenue Growth but Losses Continue Aug 07, 2025

Godavari Biorefineries Secures Chinese Patent for Breakthrough Anti-Cancer Molecule Jul 22, 2025

More news about Godavari Biorefineries

16Jul 25

Godavari Biorefineries Secures Chinese Patent for Promising Cancer Treatment Compound

Godavari Biorefineries has been granted a patent by the China National Intellectual Property Administration for a compound showing promise in cancer treatment. The patent, titled '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER,' covers a novel class of compounds that have demonstrated strong inhibitory effects on cancer and cancer stem cells in vitro, particularly against breast and prostate cancer. This development could strengthen the company's position in the pharmaceutical and biotechnology sectors, potentially leading to new collaborations and licensing opportunities in the Chinese market.

15Jul 25

Godavari Biorefineries Secures Chinese Patent for Promising Cancer Treatment Compound

Godavari Biorefineries has been granted a patent by the China National Intellectual Property Administration for a novel compound showing potential in cancer treatment. The patent, titled '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER,' covers compounds that have demonstrated strong inhibitory effects on cancer and cancer stem cells, particularly in breast and prostate cancer. This development marks Godavari Biorefineries' expansion into pharmaceutical research and could open new revenue streams for the company.

07Jul 25

Godavari Biorefineries Secures Anti-Cancer Patent in UK, Spain, and EU Countries

Godavari Biorefineries has received confirmation of its anti-cancer patent in the UK, Spain, and other EU countries. The company is currently conducting clinical trials for this innovative treatment. This development marks a significant expansion beyond the company's traditional biorefinery operations into the pharmaceutical sector, potentially opening new revenue streams and market opportunities.

04Jul 25

Godavari Biorefineries Secures European Patent for Novel Anticancer Molecule, Reports Mixed Financial Results

Godavari Biorefineries obtained a European patent for a novel anticancer molecule, validated in Spain and the UK. Q4 results show a 10.37% increase in net profit to ₹71.93 crore, despite a 5.80% revenue decline. Full-year results reveal a 10.88% revenue growth to ₹1,870.25 crore, but a net loss of ₹23.41 crore.

03Jul 25

Godavari Biorefineries: European Patent Secured for Anticancer Molecule

Godavari Biorefineries has been granted a European patent for a new anti-cancer molecule, validated in Spain, UK, and under the Unitary Patent system. The molecule is described as potent against both cancer and cancer stem cells. This development represents a significant diversification from the company's traditional biorefinery operations and could potentially lead to new revenue streams. In recent financial results, the company reported a 10.37% increase in Q4 net profit to ₹71.93 crore, despite a 5.80% revenue decline. However, full-year results showed a net loss of ₹23.41 crore, with revenue growing 10.88% to ₹1,870.25 crore.

09Apr 25

Godavari Biorefineries Achieves Record 24.65 Lakh Tons of Sugarcane Crushing at Sameerwadi Unit

Godavari Biorefineries Limited's Sameerwadi unit has set a new company record by crushing 24.65 lakh tons of sugarcane, the highest in the company's history. This achievement, announced on April 8, 2025, signifies improved operational capabilities and potentially increased sugar production. The milestone could strengthen the company's position in India's competitive sugar industry, though its impact on financial performance remains to be seen.

08Apr 25

Godavari Biorefineries Hits Record Sugarcane Crushing Milestone at Sameerwadi Unit

Godavari Biorefineries Limited's Sameerwadi unit has set a new company record by crushing over 24.65 lakh tons of sugarcane, as announced on April 8, 2025. This achievement marks the highest crushing volume in the company's history, potentially leading to increased sugar production, improved by-product utilization, and enhanced operational efficiency. The milestone underscores GBL's growing capacity in the sugar industry and could positively impact its market position and financial performance.